Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients

被引:0
作者
Pauksen, K
Linde, A
Lonnerholm, G
Ljungman, P
Sjolin, J
机构
[1] UNIV UPPSALA HOSP,DEPT INFECT DIS,S-75185 UPPSALA,SWEDEN
[2] UNIV UPPSALA HOSP,DEPT PEDIAT,S-75185 UPPSALA,SWEDEN
[3] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT MED,S-10401 STOCKHOLM,SWEDEN
[4] SWEDISH INST INFECT DIS CONTROL,DEPT VIROL,STOCKHOLM,SWEDEN
关键词
measles; T cells; B cells; vaccination; bone marrow transplantation;
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Six patients who were seronegative to measles after autologous bone marrow transplantation (ABMT) were vaccinated with a live attenuated measles vaccine. The specific T helper cell response was studied by measuring lymphocyte proliferation induced by measles antigen and B cell response by measles specific IgG by ELISA. Blood samples were drawn before, at 1-3 months, and at 1 year after vaccination. It was found that a preexisting T cell response correlated with an impaired B cell response 1 year after vaccination (r = 0.83, P = 0.04), whereas no correlation was found between IgG titers before vaccination and IgG titer increase, or T cell response after vaccination. Furthermore, there was a transient negative correlation between the T cell response at 1-3 months after vaccination and the T cell response before vaccination (r=-0.90, P=0.04) that became positive at 1 year after vaccination (r=0.90, P=0.02). In conclusion, in patients seronegative to measles who were revaccinated with measles vaccine after ABMT, a pre-existing T cell response correlated with an impaired B cell response, while pre-existing low-level IgG antibodies had no significant influence on the IgG titer rise. A sustained T cell response to measles antigen before vaccination may thus be one possible explanation for measles vaccine failure in ABMT patients.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 21 条
[1]   DELAYED EXCESS MORTALITY AFTER EXPOSURE TO MEASLES DURING THE 1ST 6 MONTHS OF LIFE [J].
AABY, P ;
BUKH, J ;
KRONBORG, D ;
LISSE, IM ;
DASILVA, MC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (02) :211-219
[2]   METHODS FOR SCREENING THE NATURALLY ACQUIRED AND VACCINE-INDUCED IMMUNITY TO THE MEASLES-VIRUS [J].
CHRISTENSON, B ;
BOTTIGER, M .
BIOLOGICALS, 1990, 18 (03) :207-211
[3]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[4]  
GINDLER JS, 1992, EPIDEMIOL REV, V267, P1936
[5]  
GOOD RA, 1956, PEDIATRICS, V18, P109
[6]  
Hammarstrom V., 1995, Blood, V86, p105A
[7]   ENDERS LIVE MEASLES-VIRUS VACCINE WITH HUMAN IMMUNE GLOBULIN .2. EVALUATION OF EFFICACY [J].
HILLEMAN, MR ;
HALENDA, R ;
WEIBEL, R ;
BUYNAK, EB ;
GOLDNER, H ;
STOKES, J .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1962, 103 (03) :372-&
[8]   MEASLES AND MEASLES IMMUNITY IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
KRASINSKI, K ;
BORKOWSKY, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (17) :2512-2516
[9]   CLINICAL AND SUBCLINICAL REACTIVATIONS OF VARICELLA-ZOSTER VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
LJUNGMAN, P ;
LONNQVIST, B ;
GAHRTON, G ;
RINGDEN, O ;
SUNDQVIST, VA ;
WAHREN, B .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (05) :840-847
[10]   LYMPHOCYTE-RESPONSES AFTER CYTOMEGALO-VIRUS INFECTION IN BONE-MARROW TRANSPLANT RECIPIENTS - A ONE-YEAR FOLLOW-UP [J].
LJUNGMAN, P ;
LONNQVIST, B ;
WAHREN, B ;
RINGDEN, O ;
GAHRTON, G .
TRANSPLANTATION, 1985, 40 (05) :515-520